Related Experiment Video
Updated: May 24, 2026

Methodology for Accurate Detection of Mitochondrial DNA Methylation
Published on: May 20, 2018
Mitochondrial regulation of epigenetics and its role in human diseases
Sheroy Minocherhomji1, Trygve O Tollefsbol, Keshav K Singh
1Wilhelm Johannsen Centre for Functional Genome Research, Institute for Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark. sheroy@sund.ku.dk
Abstract:
Most pathogenic mitochondrial DNA (mtDNA) mutations induce defects in mitochondrial oxidative phosphorylation (OXPHOS). However, phenotypic effects of these mutations show a large degree of variation depending on the tissue affected. These differences are difficult to reconcile with OXPHOS as the sole pathogenic factor suggesting that additional mechanisms contribute to lack of genotype and clinical phenotype correlationship. An increasing number of studies have identified a possible effect on the epigenetic landscape of the nuclear genome as a consequence of mitochondrial dysfunction. In particular, these studies demonstrate reversible or irreversible changes in genomic DNA methylation profiles of the nuclear genome. Here we review how mitochondria damage checkpoint (mitocheckpoint) induces epigenetic changes in the nucleus. Persistent pathogenic mutations in mtDNA may also lead to epigenetic changes causing genomic instability in the nuclear genome. We propose that "mitocheckpoint" mediated epigenetic and genetic changes may play key roles in phenotypic variation related to mitochondrial diseases or host of human diseases in which mitochondrial defect plays a primary role.
Insights
Mitochondrial DNA mutations cause defects, but tissue variation suggests other factors. Mitochondrial dysfunction can trigger epigenetic changes in the nuclear genome, influencing disease presentation.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- Mitochondrial DNA (mtDNA) mutations often impair oxidative phosphorylation (OXPHOS), but clinical outcomes vary significantly across tissues.
- This variability suggests that OXPHOS defects alone do not fully explain genotype-phenotype correlations in mitochondrial diseases.
- Emerging evidence links mitochondrial dysfunction to epigenetic alterations in the nuclear genome, including DNA methylation changes.
Purpose of the Study:
- To review the mechanisms by which the mitochondria damage checkpoint (mitocheckpoint) induces epigenetic modifications in the nucleus.
- To explore the role of persistent mtDNA mutations in driving epigenetic changes and nuclear genomic instability.
- To propose that mitocheckpoint-mediated epigenetic and genetic alterations are key contributors to phenotypic variation in mitochondrial and other diseases with mitochondrial involvement.
Main Methods:
- Literature review of studies investigating mitochondrial dysfunction and epigenetic changes.
- Analysis of research on the mitochondria damage checkpoint (mitocheckpoint) and its nuclear effects.
- Synthesis of findings on mtDNA mutations, nuclear DNA methylation, and genomic instability.
Main Results:
- Mitochondrial dysfunction, particularly from pathogenic mtDNA mutations, can lead to epigenetic alterations in the nuclear genome.
- The mitocheckpoint is implicated in mediating these stress responses and inducing changes in nuclear DNA methylation.
- Persistent mtDNA defects may contribute to genomic instability through these epigenetic pathways.
Conclusions:
- Epigenetic modifications in the nuclear genome, triggered by mitochondrial dysfunction and the mitocheckpoint, are crucial for understanding phenotypic variability.
- These epigenetic and genetic changes offer a potential explanation for the complex relationship between genotype and clinical presentation in mitochondrial diseases.
- Targeting these pathways may hold therapeutic potential for a range of human diseases linked to mitochondrial defects.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Animal Mitochondrial Genetics
Mitochondria
Mitochondrial Membranes

